Evidence map›Paper›PMID 25466889›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2015

Phosphorylation of tyrosine 285 of PAK1 facilitates βPIX/GIT1 binding and adhesion turnover.

Alan Hammer, Peter Oladimeji, Luis E De Las Casas, Maria Diakonova

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. PAK1 translocates into nucleus in response to prolactin but not to estrogen.Biochemical and biophysical research communications · 2016
    Article
  11. Article
  12. Src tyrosyl phosphorylates cortactin in response to prolactin.Biochemical and biophysical research communications · 2015
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Alan HammerDepartments of *Biological Sciences and Pathology, University of Toledo, Toledo, Ohio, USA.
Peter OladimejiDepartments of *Biological Sciences and Pathology, University of Toledo, Toledo, Ohio, USA.
Luis E De Las CasasDepartments of *Biological Sciences and Pathology, University of Toledo, Toledo, Ohio, USA.
Maria DiakonovaDepartments of *Biological Sciences and Pathology, University of Toledo, Toledo, Ohio, USA mdiakon@utnet.utoledo.edu.
University of Toledo · US

Funding

Role of JAK2-PAK1 interaction in prolactin-dependent signalingR01DK088127 · NIDDK · UNIVERSITY OF TOLEDO · PI DIAKONOVA, MARIA · 2010 to 2014
$1.5M
NIDDK NIH HHS R01 DK088127NIDDK NIH HHS R01-DK88127
6 · The paper itself

Abstract

The p21-activated serine-threonine kinase (PAK1) regulates cell motility and adhesion. We have previously shown that the prolactin (PRL)-activated tyrosine kinase JAK2 phosphorylates PAK1 in vivo and in vitro and identified tyrosines 153, 201, and 285 in PAK1 as sites of JAK2 tyrosyl phosphorylation. Here, we further investigate the role of the tyrosyl phosphorylated PAK1 (pTyr-PAK1) in regulation of cell adhesion. We use human breast cancer T47D cell lines that stably overexpress PAK1 wild type or PAK1 Y3F mutant in which these 3 JAK2 phosphorylation sites were mutated to phenylalanine. We demonstrate that PRL/JAK2-dependent phosphorylation of these tyrosines promotes a motile phenotype in the cells upon adhesion, participates in regulation of cell adhesion on collagen IV, and is required for maximal PAK1 kinase activity. Down-regulation of PAK1 abolishes the effect of PAK1 on cell adhesion. We show that the tyrosyl phosphorylation of PAK1 promotes PAK1 binding to β-PAK1-interacting guanine-nucleotide exchange factor (βPIX) and G protein-coupled receptor kinase-interacting target 1 (GIT1), phosphorylation of paxillin on Ser273, and formation and distribution of adhesion complexes. Using phosphospecific antibodies (Abs) directed to single phosphorylated tyrosines on PAK1, we identified Tyr285 as a site of PRL-dependent phosphorylation of PAK1 by JAK2. Furthermore, using PAK1 Y285F mutant, we provide evidence for a role of pTyr285 in cell adhesion, enhanced βPIX/GIT1 binding, and adhesion turnover. Our immunohistochemistry analysis demonstrates that pTyr285- PAK1 may modulate PAK1 signaling during tumor progression.

Indexed as

Adaptor Proteins, Signal TransducingBlotting, WesternBreast NeoplasmsCell AdhesionCell Cycle ProteinsCell MovementCell ProliferationFemaleFluorescent Antibody TechniqueHumansImmunoenzyme TechniquesImmunoprecipitationp21-Activated KinasesPaxillinPhosphorylationProtein BindingAdaptor Proteins, Signal TransducingCell Cycle ProteinsGIT1 protein, humanp21-Activated KinasesPAK1 protein, humanPaxillinRho Guanine Nucleotide Exchange FactorsTyrosinebreast cancer cellscell spreadingJAK2 kinaseprolactin

Identifiers

PMID25466889
PMCPMC4422366
OpenAlexW2037777502

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.